Dublin, Dec. 11, 2023 (GLOBE NEWSWIRE) — The “Biobanks – Global Strategic Business Report” report has been added to ResearchAndMarkets.com’s offering.
Global Biobanks Market to Reach $131.1 Billion by 2030
The global market for Biobanks estimated at US$69.3 Billion in the year 2022, is projected to reach a revised size of US$131.1 Billion by 2030, growing at a CAGR of 8.3% over the analysis period 2022-2030. Physical / Real, one of the segments analyzed in the report, is projected to record 7.9% CAGR and reach US$99.2 Billion by the end of the analysis period. Growth in the Virtual segment is estimated at 9.8% CAGR for the next 8-year period.
The U.S. Market is Estimated at $24.6 Billion, While China is Forecast to Grow at 9.4% CAGR
The Biobanks market in the U.S. is estimated at US$24.6 Billion in the year 2022. China, the world’s second largest economy, is forecast to reach a projected market size of US$15.1 Billion by the year 2030 trailing a CAGR of 9.4% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 7% and 7.6% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 8.2% CAGR.
Select Competitors (Total 99 Featured)
- AMS Biotechnology (Europe) Limited
- Bay Biosciences LLC
- BioIVT & Elevating Science
- BioLifeSolutions Inc.
- Biovault Technical
- CENTOGENE NV
- CTI Biotech
- Cureline, Inc.
- Firalis S.A.
- Hamilton Company
- Merck KGaA
- ProteoGenex, Inc.
- Tecan Trading AG
- Thermo Fisher Scientific Inc.
- US Biolab Corporation, Inc.
- VWR International LLC
Key Attributes:
| Report Attribute | Details |
| No. of Pages | 402 |
| Forecast Period | 2022 – 2030 |
| Estimated Market Value (USD) in 2022 | $69.3 Billion |
| Forecasted Market Value (USD) by 2030 | $131.1 Billion |
| Compound Annual Growth Rate | 8.3% |
| Regions Covered | Global |
MARKET TRENDS & DRIVERS
- Growing Research Focus on Regenerative Medicine Expands Opportunities for Biobanks
- Global Regenerative Medicine Market Size in US$ Billion for 2019, 2021, 2023 and 2025
- Global Stem Cell & Regenerative Medicine Market by Product (in %) for the Year 2022
- Uptrend in Translational Research and Personalized Medicine to Benefit Demand
- Robust Outlook for Personalized Medicine to Create a Parallel Opportunity for Biobanks: Global Market for Personalized Medicines (In US$ Billion) for Years 2023 2025, 2027, 2029 and 2031
- Growing Focus on Personalized Medicine for Oncology Domain Raises the Importance of Biobanking Services
- Global Breakdown of Total Number of Cancer Cases by Type: 2020
- Global Cancer Incidence: Number of New Cancer Cases in Million for the Years 2018, 2020, 2025, 2030, 2035 and 2040
- Biobanks Poised to Benefit from the Increasingly Robust Outlook for Digital Health
- Global Market for Digital Health (In US$ Billion) for Years 2023, 2025, and 2027
- Rise Genomic Research Initiatives Drives Growth Opportunities
- Technological Advancements Bring in Transformative Changes
- AI and ML Advancements to Benefit Biobanks
- Biobanks Enter the Age of Big Data
- Use of Laboratory Information Management System Software Gains Momentum
- Biobanks Turn to Customized LIMS Software
- Biobanking Jumpstarts to a New Era with Imaging Biobanks
- Imaging Biobanks Dedicated to Radiogenomics
- Virtual Biobanks Emerge as Bankable Option for Access to Research Resources
- Virtual Biobanks amid Pandemic
- Strong Outlook for Gene Therapy to Drive Demand for Biobanking Services
- World Gene Therapy Market in US$ Million:L 2020, 2022, 2024, 2026, 2028, 2030
- Uptrend in Drug Discovery Research Builds Robust Momentum
- Global Drug Discovery Market Size (in US$ Billion) for the Years 2020, 2022, 2024, 2026, 2028, ad 2030
- Human iPSC Banks: A Review of Emerging Opportunities
- Human iPSC Banks Worldwide: An Overview
- Automated Storage Systems Gain Importance
- Prospective Collection to Gather Steam
- Rise in R&D Initiatives in Life Sciences & Pharmaceutical Industries Boosts Prospects
- Year Spending (US$ Billion) 2015 150 2016 160 2017 169 2018 182 2019 190 2020 204 2021 235 2022 245 2023 259 2024 270 2025 282
- High Prevalence of Chronic Diseases and Growing Focus Long-Term Management & Preventative Healthcare Widens Growth Opportunities
- Global Cost of Chronic Diseases (In US$ Billion) for the Years 2018 and 2030
- World Diabetes and Population Statistics (2019, 2030 & 2045)
- Fatalities by Heart Conditions – Estimated Percentage Breakdown for Cardiovascular Disease, Ischemic Heart Disease, Stroke, and Others
- Global Annual Medical Cost of Cardiovascular Diseases in US$ Billion (2010-2030)
MARKET OVERVIEW
- Growing Focus on Early Diagnosis and Treatment of Chronic Diseases and Genetic Conditions Cornerstone for the Growth of Biobanks
- Global Economic Update
- World Shifts to an Endemic COVID-19 Strategy With Focus on Multilateral Approach to Managing Future Pandemics
- From Pandemic to War & Inflation: “Gloomy Outlook for 2023 Despite Signs of Easing Inflationary Conditions”
- Here’s What’s Causing Inflationary Pressures in the Global Market
- War-Induced Commodity Price Increases & Broad Based Price Pressures Mark the Return of Global Inflation to the Highest Level Seen Since 1996: Global Inflation Rates (In %) for the Years 2019 Through 2024
- Although Facing a Lower Recession Risk, Global Economic Growth in 2023 to Slowdown Amid War, Inflation, Elevated Interest Rates & Marginal Easing of Inflation: World Economic Growth Projections (Real GDP, Annual % Change) for the Years 2020 Through 2024
- Laboratory Equipment and Supplies Industry Experience Mixed Impact
- Competition
- Biobanks – Global Key Competitors Percentage Market Share in 2023 (E)
- Biobanks Competitor Market Share Scenario Worldwide (in %): 2022E
- Competitive Market Presence – Strong/Active/Niche/Trivial for Players Worldwide in 2023 (E)
- Recent Market Activity
For more information about this report visit https://www.researchandmarkets.com/r/xguesy
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
